BICO Group AB (publ) provides hardware, laboratory automation, and software solutions in North America, Europe, Asia, and internationally. It operates through two segments: Life Science Solutions and Lab Automation. The …
Industry Peers
Medical Devices| Headline | Source | Time |
|---|---|---|
Today | ||
BICO Group AB (CLLKF) (Q2 2026) Earnings Call Highlights: Organic Growth and Margin Expansion ... Gross margin surged to 59% and adjusted EBITDA turned positive, driven by strong consumables sales and a major EUR50 million licensing deal. | ||
Older | ||
BICO Group AB (CLLKF) Q1 2026 Earnings Call Highlights: Navigating Challenges with Strong ... BICO Group AB (CLLKF) reports 11% organic growth amidst currency headwinds and restructuring costs, while focusing on AI-driven lab automation and financial strengthening. | ||
BICO Group AB (CLLKF) Q4 2025 Earnings Call Highlights: Navigating Challenges with Strategic ... BICO Group AB (CLLKF) ends 2025 with robust lab automation growth and a strong cash position despite facing sales headwinds. | ||
BICO Group (OM:BICO): Losses Compound at 43% Annually, Undermining Turnaround Narrative BICO Group (OM:BICO) remains in the red, with net losses increasing at an annual rate of 43% over the past five years and a persistently negative profit margin. While the company is projected to stay unprofitable for at least the next three years, analysts expect revenue to grow at 4.38% per year, slightly outpacing the Swedish market average of 3.7%. Amid weak share price stability and no track record of profitability, BICO’s 1x Price-To-Sales Ratio stands out as considerably lower than both... | ||
BICO Group AB (CLLKF) Q3 2025 Earnings Call Highlights: Strong Organic Growth Amidst Challenges BICO Group AB (CLLKF) reports robust sales growth and significant orders, despite facing impairments and funding constraints. | ||